CoChat

Antidepressant prevalence for youths: a multi‐national comparison

Open access
Zito, Julie M., Tobi, Hilde, de Jong‐van den Berg, Lolkje T.W., Fegert, Joerg M., Safer, Daniel J., Janhsen, Katrin, Hansen, Dorte Gilså, Gardner, James F., Glaeske, Gerd · 2006 · Pharmacoepidemiology and Drug Safety
Cited by 97

The DOI matches its Crossref record.

Abstract

Objective: To compare antidepressant prevalence data in youths across three western European countries (Denmark, Germany, and the Netherlands) with US regional data in terms of age and gender and to show proportional subclass antidepressant (ATD) use. Method: A population‐based analysis of administrative claims data for the year 2000 was undertaken in 0 to 19‐year‐old enrollees who were part of the insured populations from four countries having a total of from 72,570 to 480,680 members. Results: ATD medication utilization in the US dataset (1.63%) exceeded that of three Western European countries (prevalence ranged from 0.11 to 0.54%) by at least 3‐fold. There were major variations in the use of subclasses: tricyclic antidepressants (TCAs) predominated in Germany while selective serotonin reuptake inhibitors (SSRIs) predominated in the US, Denmark and the Netherlands. Conclusions: Cross‐national variations should be further explored to understand the factors related to these differences and how prevalence differences relate to effectiveness and safety. Community‐based cohorts should be followed to establish outcomes in the usual practice setting. Copyright © 2006 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pds.1254

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Zito, J. M., Tobi, H., de Jong‐van den Berg, L. T. W., Fegert, J. M., Safer, D. J., Janhsen, K., Hansen, D. G., Gardner, J. F., & Glaeske, G.
Venue
Pharmacoepidemiology and Drug Safety
Publisher
Wiley
Published
2006-05-22
Volume
15
Issue
11
Pages
793-798
ISSN
  • 1053-8569 (ISSN-L)
  • 1099-1557
OpenAlex
W2034858312
Cited by
97
References
0
FWCI
8.85
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.